Vanderlei Biolchi
Universidade Federal do Rio Grande do Sul
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Vanderlei Biolchi.
Cancer Investigation | 2008
Brasil Silva Neto; Walter Jose Koff; Vanderlei Biolchi; Cleber Brenner; Karlo D. Biolo; Poli Mara Spritzer; Ilma Simoni Brum
Variations in transcriptional activity of the androgen receptor (AR) are related to polymorphic CAG and GGC repeats in exon 1 of the AR gene. We investigated the association between CAG and GGC repeat length and the risk of prostate cancer in a case-control study from a Brazilian population. We evaluated 49 patients and 51 healthy controls. DNA was extracted from peripheral leukocytes and the AR gene was analyzed by fragment analysis (GeneMapper software, Applied Biosystems, Foster City, California, USA). CAG and GGC mean lengths were not different between cases and controls. The risk for prostate cancer was higher for CAG repeats ≤ 21 (OR = 2.44 [95% CI 1.03–5.81]) as well as for total repeat lengths (CAG + GGC) ≤37 (OR = 2.46 [95% CI 0.98–6.18]). GGC repeats (≤17 and > 17) were not associated with risk for prostate cancer (OR = 1.13 [95% CI 0.47–2.75]). In conclusion, fewer number of CAG repeats and total repeats (CAG + GGC) in the AR gene may be associated with increased risk for prostate cancer.
Human Immunology | 2013
Francis Maria Báo Zambra; Vanderlei Biolchi; Ilma Simoni Brum; José Artur Bogo Chies
Benign prostatic hyperplasia (BPH) and prostate cancer (PCa) are two chronic conditions, very common in aged men, that have been associated to inflammatory process. Chemokines and their receptors are recognized as critical mediators of inflammatory responses, they regulate immune cell migration and are implicated in tumor pathogenesis. The impact of two chemokine receptor gene polymorphisms, CCR2-64I (rs1799864) and CCR5-Δ32 (rs333), was evaluated in BPH and PCa. 385 DNA samples (130 BPH, 136 PCa, 119 healthy control) were genotyped. The allele frequencies were similar among control, BPH and PCa groups. Median of serum PSA levels was different between groups: 0.79, 1.45 and 6.91 ng/mL in control, BPH and PCa groups, respectively (all p<0.001). The prostate volume median was 20.00 cm(3) in the control group, thus, lower than BPH (35.35 cm(3)) and PCa (35.80 cm(3)) (both p<0.001), nevertheless no statistical significant difference was observed between BPH and PCa patients (p=0.172). Remarkably, CCR2-64I was a protective factor to PCa when compared with BPH (OR=0.550; 95%CI=0.311-0.975), although the statistically significant difference was lost after correction for multiple comparisons. No significant associations of CCR5-Δ32 variant were observed with BPH, PCa or PCa clinicopathologic status. Our data suggest the influence of CCR2-64I variant in the development of prostate cancer.
International Braz J Urol | 2012
Vanderlei Biolchi; Brasil Silva Neto; Walter Jose Koff; Ilma Simoni Brum
Benign prostatic hyperplasia (BPH) is a very frequent age-related proliferative abnormality in men. Polymorphic CAG repeat in the androgen receptor (AR) can alter transactivation of androgen-responsive genes and potentially influence BPH risk. We investigated the association between CAG repeat length and risk of BPH in a case-control study of a Brazilian population. We evaluated 214 patients; 126 with BPH and 88 healthy controls. DNA was extracted from peripheral leucocytes and the AR gene was analyzed using fragment analysis. Hazard ratio (HR) and 95% confidence interval were estimated using logistic regression models. Mean CAG length was not different between patients with BPH and controls. The CAG repeat length was examined as a categorical variable (CAG ≤ 21 vs. CAG > 21 and CAG ≤ 22 vs. CAG > 22) and did not differ between the control vs. the BPH group. We found no evidence for an association between AR CAG repeat length in BPH risk in a population-based sample of Brazilians.
Revista do Instituto de Laticínios Cândido Tostes | 2012
Camila Agostini; Caroline Schwertner Kreling; Ivan Cunha Bustamante-Filho; Claucia Fernanda Volken de Souza; Vanderlei Biolchi; Adriane Pozzobon
Considering the possible incidence of Listeria monocytogenes in raw foods and their pathogenicity and health risk, this study aimed to compare techniques for extraction of bacterial DNA from milk samples and investigate the presence of L. monocytogenes by Polymerase Chain Reaction (PCR) in raw milk. We tested four different extraction protocols (generally identified: A, B, C, and D) for isolation of bacterial DNA directly from milk. In all of them was obtained identifying the product of 702 bp (base pairs) corresponding to the listeriolysin gene from L. monocytogenes . The protocol B containing proteinase K and phenol buffered, was chosen for the extraction of DNA from milk samples from eight dairy farms within the RS. The subsequent PCR amplification with DNA obtained by the protocol B allowed the identification of L. monocytogenes from 10 3 CFU/mL. None of the samples was positive for the producer L. monocytogenes by PCR or by conventional microbiological analysis. With this study it is concluded that the tested protocols, the protocol B was more effective for the detection of L. monocytogenes by PCR. Moreover, for the samples of the producers, the result PCR technique was obtained in a shorter time than conventional analysis of L. monocytogenes , which may allow earlier treatment of infected animals and thus avoid losses to the producer.
Journal of Ovarian Research | 2015
Ângela Marcon D’Avila; Vanderlei Biolchi; Edison Capp; Helena von Eye Corleta
Molecular Biology Reports | 2013
Vanderlei Biolchi; Brasil Silva Neto; Diego Bromfman Pianta; Walter Jose Koff; Milton Berger; Ilma Simoni Brum
Seminário de Iniciação Científica | 2014
Helouise Richardt Medeiros; Daiane Gandor Jantsch; Henrique Sulzbach de Oliveira; Márcia Oettert; Vanderlei Biolchi; Adriane Pozzobon
Archive | 2014
Henrique Sulzbach de Oliveira; Vanderlei Biolchi; Daiane Gandor Jantsch; Helouise Richardt Medeiros; Luciana Knabben de Oliveira Becker Delving; Márcia Inês Goettert; Roberto Reckziegel; Ilma Simoni Brum; Adriane Pozzobon
Archive | 2013
Caetana Machado Ledur; Vanderlei Biolchi; Brasil Silva Neto; Milton Berger; Ilma Simoni Brum
Clinical & Biomedical Research | 2013
Patrícia Borba Martiny; Maria Eduarda Azambuja Amaral; Gustavo Dias Ferreira; Ana Caroline Hillebrand; Gisele Branchini; Brasil Silva Neto; Vanderlei Biolchi; Ilma Simoni Brum da Silva